Live Breaking News & Updates on Concomitant Erenumab

Stay updated with breaking news from Concomitant erenumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting

Highlights Include Multiple Presentations Addressing Safety and Efficacy of TrudhesaSEATTLE, April 11, 2023 Impel Pharmaceuticals , a commercial-stage pharmaceutical company developing. | April 11, 2023 ....

United States , Melyssa Weible , Jennifer Robblee , Zubair Ahmed , Alexander Feoktistov , Sutapa Ray , Elixir Health Public Relations , Impel Pharmaceuticals , American Academy Of Neurology , Synergy Integrative Headache Center , Barrow Neurological Institute , Impel Pharmaceuticals Inc , Exchange Commission , Sectional Survey Of Prevailing Opinions , American Academy , Annual Meeting , Cross Sectional Survey , Prevailing Opinions , Drug Interactions Between , Migraine Management Using , Model Based Approach , Concomitant Erenumab , Migraine Patients , Cleveland Clinic , Concomitant Triptan , Precision Olfactory Delivery ,